Imidazopyridazine compounds

Details for Australian Patent Application No. 2006227300 (hide)

Owner Eli Lilly and Company

Inventors Hembre, Erik James; Johnston, Richard Duane; Hamdouchi, Chafiq; Takakuwa, Takako; Rupp, Michael John; Collins, Elizabeth Aaron; Lu, Jianliang; Barbosa, Heather Janelle; Hipskind, Philip Arthur; Thompson, Richard Craig

Agent Spruson & Ferguson

Pub. Number AU-B-2006227300

PCT Pub. Number WO2006/102194

Priority 60/663,816 21.03.05 US

Filing date 20 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 2 February 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/102194 Priority application(s): WO2006/102194

2 February 2012 Application Accepted

  Published as AU-B-2006227300

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227302-Connection forwarding

2006227297-Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors